Novacyt investor relations
WebNovacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases. Novacyt exists to help protect public health from the world’s … WebMay 30, 2024 · See Novacyt funding rounds, investors, investments, exits and more. Evaluate their financials based on Novacyt's post-money valuation and revenue.
Novacyt investor relations
Did you know?
WebNOVACYT has 8 current employee profiles, including Chief Executive Officer Graham Mullis. Graham Mullis Chief Executive Officer Anthony Dyer Chief Corporate Development Officer Ruth Powell Managing Director of NOVAprep & Lab21 Services Paul Eros Corporate Business Development Director Mandy Cowling Corporate & Investor Relations Manager WebNovacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. They are passionate about their business and the healthcare industry sector they work with and would like to thank you for your ...
WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the ticker LSE:NCYT . NOVACYT is funded by 4 investors. Kreos Capital and YA Global Master SPV are the most recent investors. NOVACYT has acquired 4 organizations. WebFeb 10, 2024 · Investor Relations Novacyt SA ALNOV Ownership Morningstar Rating Rating as of Feb 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ...
WebMar 22, 2024 · Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology... WebPlease get in touch using the details below. Alternatively, use the direct contact form below. We’re looking forward to hearing from you Mandy Cowling Corporate & Investor Relations … Advisor and Investor Contacts; AIM Rule 26 information; Corporate Governance; Our … Company York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG …
WebNOVACYT develops cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Vélizy-villacoublay, Ile-de-France, France 101-250 Post-IPO Debt Public www.novacyt.com/ 35,439 …
WebSolidifying this position, Novacyt was among the first to respond to the COVID-19 pandemic in 2024, providing a rapid and reliable gold standard SARS-CoV-2 test kit that the WHO approved. ... E [email protected]. www.novacyt.com. Registered Address: Novacyt Group (France) 13 Avenue Morane Saulnier 78140. Vélizy-Villacoublay France. phim silencedWebJul 7, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year ended 30 June 2024 … phimsllc.comWebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the … phim single infernoWebNovacyt Group (UK) Unit 1, Watchmoor Point, Watchmoor Road, Camberley, Surrey GU15 3AD. T +44 (0) 1276 600081. F +44 (0) 1276 600151. E [email protected]. … phim silicon valley season 5WebThe Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in … tsmc leasing llcWebMar 31, 2024 · Novacyt SA NYZ Ownership Morningstar Rating Rating as of Mar 6, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns … phim slasherWebJun 30, 2024 · Novacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker) phim sixth sense